EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
33 hedge funds and large institutions have $297M invested in ESSA Pharma in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
6
Increased
5
Reduced
10
Closed
4
Calls
$492K
Puts
$277K
Net Calls
+$215K
Net Calls Change
+$16K
Top Buyers
Top Sellers
1 |
Morgan Stanley
New York
|
-$35.6M |
2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.27M |
3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$2.39M |
4 |
Citadel Advisors
Miami,
Florida
|
-$1.93M |
5 |
D.E. Shaw & Co
New York
|
-$1.14M |